Blue Matter Blog
September 20, 2018
Part One in a Six-Part Series on Oncology Product Commercialization The oncology market continues to grow at a phenomenal pace, with worldwide revenues expected to increase from $104B in 2017 to $233B in 20241. Fueling this revenue growth is a rich pipeline, with more than 700 molecules in late-stage development – a 60% increase from …
As a founder and managing partner, Ashwin brings 17+ years of life science consulting experience to Blue Matter. Prior to starting Blue Matter, he was Senior VP, Head of Brand Management / Business Development at Campbell Alliance. He is a physician and MBA by training and his specialties include product and portfolio strategy.
As a founder and managing partner of Blue Matter, Emily brings over 20 years of life science experience. Prior to Blue Matter, Emily was Senior VP and head of the San Francisco office for Campbell Alliance. Her specialties include product and portfolio strategy and oncology product launches.
As head of Blue Matter Europe, George brings extensive experience from 16+ years in life science consulting. Previously, George was GM / Head of Europe for Campbell Alliance. His specialties are commercial excellence, organizational design and customer engagement strategy.
Jeron brings 15+ years of life science experience, including more than 10 years in consulting. Previously, Jeron was Corporate Development and Commercial Excellence Lead at Campbell Alliance. His specialties include product, portfolio, and corporate strategy in oncology and diagnostics.
Thomas has 11+ years of experience in life science consulting (bio-pharma / diagnostic). He was formerly VP of Brand Management and Medical Affairs at Campbell Alliance. His specialties include product commercialization and Medical Affairs organization development in oncology and rare diseases.
With over 10 years in research and consulting for the life sciences, Mary’s primary focus is on product strategy, franchise/portfolio strategy, launch planning, and commercial excellence in oncology and other TAs. She has a PhD in Biology from MIT and also hails from Campbell Alliance.
Jonny has over 12 years of life sciences experience across industry and consulting. His primary focus is on launch planning, product strategy, and lifecycle management in oncology and other specialty TAs. Formerly a senior manager at Campbell Alliance, he holds a PhD in Biochemical Engineering from UCL.
Dirk brings extensive industry experience to Blue Matter. His background spans 25+ years, with senior commercial roles in leading biopharmaceutical companies such as Shire, Roche / Genentech, and Amgen. His specialties include commercial strategy development, lifecycle management, and marketing, with a focus on rare diseases. He has a degree in biochemistry, as well as a PhD in Molecular Immunology from the University of Basel.